Home > News > Show Me A Sign
September 15th, 2005
Show Me A Sign
Joe Alper: Initial clinical trials with some of these apoptosis detectors have shown promise, and now investigators are bringing the power of nanotechnology to bear on this effort in order to create powerful systems that would ultimately be capable of both delivering an anti-tumor drug and monitoring, in real time, if it is triggering cell death. The development of a nanotechnology-enabled apoptosis detector is one of the strategic areas of emphasis of the NCI Alliance for Nanotechnology in Cancer.
Though this work is still in its early stages, its potential is a harbinger of things to come. "Having a real-time apoptosis detector would represent a significant advance in cancer therapy, one that would let us alter treatment to reflect how each patient responds to a given set of drugs soon after being given those drugs," remarked James Olson, M.D.
Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014
Local girl does good March 22nd, 2014
Surface Characteristics Influence Cellular Growth on Semiconductor Material March 12th, 2014
The "Tipping Point" February 12th, 2014
Gold nanoparticles help target, quantify breast cancer gene segments in a living cell April 23rd, 2014
QuantuMDx announce prototype handheld lab for 15 minute malaria diagnosis and drug resistance testing April 23rd, 2014
Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014
Cloaked DNA nanodevices survive pilot mission: Successful foray opens door to virus-like DNA nanodevices that could diagnose diseased tissues and manufacture drugs to treat them April 22nd, 2014